Die Komplexität chronischer Beckenschmerzen am Beispiel der Interstitiellen Zystitis

Zusammenfassung

Die Interstitielle Zystitis ist ein chronisches Schmerzsyndrom und weniger eine reine Endorganerkrankung der Harnblase. Neue Definitions- und Nomenklaturvorschläge tragen dieser Kenntnis Rechnung. In Unkenntnis der Ätiologie und Pathogenese ist eine kausale Behandlung zurzeit nach wie vor nicht möglich. Es existiert weder ein evidenzbasierter Therapiealgorithmus noch eine sog. Standardtherapie. Die bislang unternommenen Therapieansätze sind sehr vielfältig. Die therapeutischen Ansätze können in orale, intravesikale, operative und physikalische Verfahren unterteilt werden. Auch gibt es sinnvolle ergänzende Therapieverfahren jenseits der klassischen Schulmedizin. Grundlage jeder Schmerztherapie stellt das WHO-Stufenschema dar. Unter den oralen Therapieverfahren werden z.Zt. folgende Medikamente mit unterschiedlichen Evidenzleveln empfohlen: Amitriptylin, Hydroxyzin, Pentosanpolysulfat. Viele weitere orale Medikamente werden eingesetzt, wobei der Nachweis ihrer Wirksamkeit z. T. lückenhaft ist, darunter Antikonvulsiva, L-Arginin und verschiedene Immunmodulatoren und -suppressiva. Bei den intravesikalen Therapieverfahren finden Botulinumtoxin A, Dimethylsulfoxid, Heparin und Glykosaminoglykan-Ersatzstoffe Anwendung. Unter den physikalischen Therapieverfahren gilt neben der Blasendistension die hyperbare Sauerstofftherapie als wirksame Therapieform. Bei Versagen der konventionellen Therapieverfahren stellen die operative (Teil-)Entfernung der Harnblase oder Harnumleitungsoperationen die therapeutische Ultima Ratio dar. Kontrollierte Studien zu alternativen Heilverfahren existieren kaum; recht gute Resultate bei chronischen Beckenschmerzsyndromen konnten aber mit Akupunktur als additives Therapieverfahren erreicht werden.

Abstract

The so-called interstitial cystitis is a chronic pain syndrome rather than a purely end organ disease of the urinary bladder. New suggestions for definitions and nomenclature take this into consideration. Since aetiology and pathogenesis are still unknown a treatment of the cause is still not possible. There are neither evidence-based treatment algorithms nor a so-called standard therapy. Numerous therapeutic approaches have been tried up to now. These attempts can be divided into oral, intravesical, surgical and physical procedures. There are also meaningful supplementary therapy procedures beyond the boundaries of classical school medicine. The WHO staging scheme provides the basis for every pain therapy. For the oral therapeutic procedures in current use the following medications with differing levels of evidence have been recommended: amitriptylin, hydroxyzin, pentosan polysulfate. Many other orally administered drugs have also been used although in many cases evidence of efficacy is lacking, these included anticonvulsants, L-arginine and various immunomodulators and immunosuppressants. Among the intravesical therapeutic procedures botulinum toxin A, dimethyl sulfoxide, heparin and glycosaminoglycan substitutes have been used. For the physical procedures, besides bladder distension, hyperbaric oxygen therapy shows efficacy. When the conventional therapeutic methods fail, surgical (partial) removal of the urinary bladder or urinary diversion procedures represent the therapeutic ultimo ratio. There are hardly any controlled studies on alternative curative procedures although rather good results have been obtained in chronic pelvic pain syndrome with acupuncture as an additional therapeutic modality.

Schlüsselwörter

Definition - Nomenklatur - Pathogenese - Diagnostik - klinische Studien

Key words

definition - nomenclature - aetiology - diagnosis - clinical trials

Literatur

• 1 Bade J J, Laseur M, Nieuwenburg A, Weele L T van der, Mensink H J. A placebo-controlled study of intravesical pentosanpolysulphate for the treatment of interstitial cystitis.  British Journal of Urology. 1997;  79 (2) 68-171
• 2 Badenoch A W. Chronic interstitial cystitis.  British Journal of Urology. 1971;  43 (6) 718-721
• 3 Baskin L S, Tanagho E A. Pelvic pain without pelvic organs.  J Urol. 1992;  147 (3) 683-686
• 4 Bouchelouche K, Nordling J, Hald T, Bouchelouche P. The cysteinyl leukotriene d4 receptor antagonist montelukast for the treatment of interstitial cystitis.  J Urol. 2001;  166 (5) 1734-1737
• 5 Capelli-Schellpfeffer M, Gerber G S. The use of hyperbaric oxygen in urology.  J Urol. 1999;  162 (3 Pt 1) 647-654
• 6 Cartledge J J, Davies A M, Eardley I. A randomized double-blind placebo-controlled crossover trial of the efficacy of L-arginine in the treatment of interstitial cystitis.  BJU Int. 2000;  85 (4) 421-426
• 7 Daha L K, Riedl C R, Hohlbrugger G, Knoll M, Engelhardt P F, Pfluger H. Comparative assessment of maximal bladder capacity, 0.9 % NaCl versus 0.2 M Kcl, for the diagnosis of interstitial cystitis: a prospective controlled study.  J Urol. 2003;  170 (3) 807-809
• 8 Davis E L, El Khoudary S R, Talbott E O, Davis J, Regan L J. Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial.  J Urol. 2008;  179 (1) 177-185
• 9 Emmons S L, Otto L. Acupuncture for overactive bladder: a randomized controlled trial.  Obstet Gynecol. 2005;  106 (1) 138-143
• 10 Erickson D R. Interstitial cystitis: update on etiologies and therapeutic options.  J Womens Health Gend Based Med. 1999;  8 (6) 745-758
• 11 Erickson D R, Belchis D A, Dabbs D J. Inflammatory cell types and clinical features of interstitial cystitis.  J Urol. 1997;  158 (3 Pt 1) 790-793
• 12 Forsell T, Ruutu M, Isoniemi H, Ahonen J, Alfthan O. Cyclosporine in severe interstitial cystitis.  Journal of Urology. 1996;  155 (5) 1591-1593
• 13 Franksson C. Interstitial cystitis: a clinical study of fifty-nine cases.  Acta Chirurgica Scandinavica. 1957;  113 51-62
• 14 Giannantoni A, Porena M, Costantini E, Zucchi A, Mearini L, Mearini E. Botulinum A Toxin Intravesical Injection in Patients With Painful Bladder Syndrome: 1-Year Followup.  J Urol. 2008;  179 (3) 1031-1034
• 15 Glemain P, Riviere C, Lenormand L, Karam G, Bouchot O, Buzelin J M. Prolonged hydrodistention of the bladder for symptomatic treatment of interstitial cystitis: efficacy at 6 months and 1 year.  Eur Urol. 2002;  41 (1) 79-84
• 16 Grossklaus D J, Franke J J. Vesical necrosis after hydrodistension of the urinary bladder in a patient with interstitial cystitis.  BJU Int. 2000;  86 (1) 140-141
• 17 Hanno P, Keay S, Moldwin R, Ophoven A van. International Consultation on IC-Rome, September 2004/Forging an International Consensus: progress in painful bladder syndrome/interstitial cystitis. Report and abstracts.  Int Urogynecol J Pelvic Floor Dysfunct. 2005;  16 Suppl 1 S2-S34
• 18 Hanno P M, Buehler J, Wein A J. Use of amitriptyline in the treatment of interstitial cystitis.  Journal of Urology. 1989;  141 (4) 846-848
• 19 Herwig R, Oberpenning F. [Alternative and complementary therapeutic measures in interstitial cystitis].  Urologe A. 2000;  39 (6) 551-553
• 20 Hwang P, Auclair B, Beechinor D, Diment M, Einarson T R. Efficacy of pentosan polysulfate in the treatment of interstitial cystitis: a meta-analysis.  Urology. 1997;  50 (1) 39-43
• 21 Kallestrup E B, Jorgensen S S, Nordling J, Hald T. Treatment of interstitial cystitis with Cystistat: a hyaluronic acid product.  Scand J Urol Nephrol. 2005;  39 (2) 143-147
• 22 Kirkemo A K, Miles B J, Peters J M. Use of amitriptyline in interstitial cystitis.  Journal of Urology. 1990;  143 279 (A)
• 23 Korting G E, Smith S D, Wheeler M A, Weiss R M, Foster Jr H E. A randomized double-blind trial of oral L-arginine for treatment of interstitial cystitis.  Journal of Urology. 1999;  161 (2) 558-565
• 24 Kuo H C. Urodynamic results of intravesical heparin therapy for women with frequency urgency syndrome and interstitial cystitis.  J Formos Med Assoc. 2001;  100 (5) 309-314
• 25 Kuo H C. Preliminary results of suburothelial injection of botulinum a toxin in the treatment of chronic interstitial cystitis.  Urol Int. 2005;  75 (2) 170-174
• 26 Larsen S, Thompson S A, Hald T. et al . Mast cells in interstitial cystitis.  British Journal of Urology. 1982;  54 (3) 283-286
• 27 Lasanen L T, Tammela T L, Kallioinen M, Waris T. Effect of acute distension on cholinergic innervation of the rat urinary bladder.  Urological Research. 1992;  20 (1) 59-62
• 28 Lee S W, Liong M L, Yuen K H. et al . Acupuncture versus sham acupuncture for chronic prostatitis/chronic pelvic pain.  Am J Med. 2008;  121 (1) 79.e1 – 7
• 29 Lundberg J O, Ehren I, Jansson O. et al . Elevated nitric oxide in the urinary bladder in infectious and noninfectious cystitis.  Urology. 1996;  48 (5) 700-702
• 30 Mayer R, Propert K J, Peters K M. et al . A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis.  J Urol. 2005;  173 (4) 1186-1191
• 31 Mayer R D, Howard F M. Sacral nerve stimulation: neuromodulation for voiding dysfunction and pain.  Neurotherapeutics. 2008;  5 (1) 107-113
• 32 Melchior D, Packer C S, Johnson T C, Kaefer M. Dimethyl Sulfoxide: Does It Change the Functional Properties of the Bladder Wall?.  J Urol. 2003;  170 (1) 253-258
• 33 Morales A, Emerson L, Nickel J C, Lundie M. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis.  Journal of Urology. 1996;  156 (1) 45-48
• 34 Moran P A, Dwyer P L, Carey M P, Maher C F, Radford N J. Oral methotrexate in the management of refractory interstitial cystitis.  Aust N Z J Obstet Gynaecol. 1999;  39 (4) 468-471
• 35 Nickel J C, Barkin J, Forrest J. et al . Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis.  Urology. 2005;  65 (4) 654-658
• 36 O'Reilly B A, Dwyer P L, Hawthorne G. et al . Transdermal posterior tibial nerve laser therapy is not effective in women with interstitial cystitis.  J Urol. 2004;  172 ( 5 Pt 1) 1880-1883
• 37 Oravisto K J, Alfthan O S. Treatment of interstitial cystitis with immunosuppression and chloroquine derivatives.  European Urology. 1976;  2 (2) 82-84
• 38 Parsons C L. Current strategies for managing interstitial cystitis.  Expert Opin Pharmacother. 2004;  5 (2) 287-293
• 39 Parsons C L. Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis.  Urology. 2005;  65 (1) 45-48
• 40 Parsons C L, Housley T, Schmidt J D, Lebow D. Treatment of interstitial cystitis with intravesical heparin.  British Journal of Urology. 1994;  73 (5) 504-507
• 41 Peeker R, Aldenborg F, Fall M. Complete transurethral resection of ulcers in classic interstitial cystitis.  Int Urogynecol J Pelvic Floor Dysfunct. 2000;  11 (5) 290-295
• 42 Peeker R, Haghsheno M A, Holmang S, Fall M. Intravesical bacillus Calmette-Guerin and dimethyl sulfoxide for treatment of classic and nonulcer interstitial cystitis: a prospective, randomized double-blind study [In Process Citation].  J Urol. 2000;  164 (6) 1912-1916
• 43 Peng C H, Kuo H C. Multiple intravesical instillations of low-dose resiniferatoxin in the treatment of refractory interstitial cystitis.  Urol Int. 2007;  78 (1) 78-81
• 44 Perez-Marrero R, Emerson L E, Feltis J T. A controlled study of dimethyl sulfoxide in interstitial cystitis [see comments].  Journal of Urology. 1988;  140 (1) 36-39
• 45 Perez-Marrero R, Emerson L E, Maharajh D O, Juma S. Prolongation of response to DMSO by heparin maintenance.  Urology. 1993;  41 (1 Suppl) 64-66
• 46 Peters K, Diokno A, Steinert B. et al . The efficacy of intravesical Tice strain bacillus Calmette-Guerin in the treatment of interstitial cystitis: a double-blind, prospective, placebo controlled trial.  Journal of Urology. 1997;  157 (6) 2090-2094
• 47 Peters K M, Diokno A C, Steinert B W, Gonzalez J A. The efficacy of intravesical bacillus Calmette-Guerin in the treatment of interstitial cystitis: long-term followup.  J Urol. 1998;  159 (5) 1483-1486; discussion 1486 – 1487
• 48 Peters K M, Feber K M, Bennett R C. A prospective, single-blind, randomized crossover trial of sacral vs pudendal nerve stimulation for interstitial cystitis.  BJU Int. 2007;  100 (4) 835-839
• 49 Pontari M A, Hanno P M, Ruggieri M R. Comparison of bladder blood flow in patients with and without interstitial cystitis.  Journal of Urology. 1999;  162 (2) 330-334
• 50 Propert K J, Mayer R, Nickel J C. et al . Followup of Patients With Interstitial Cystitis Responsive to Treatment With Intravesical Bacillus Calmette-Guerin or Placebo.  J Urol. 2008;  179 (2) 552-555
• 51 Rosamilia A, Cann L, Dwyer P, Scurry J, Rogers P. Bladder microvasculature in women with interstitial cystitis [see comments].  Journal of Urology. 1999;  161 (6) 1865-1870
• 52 Rosamilia A, Dwyer P L, Gibson J. Electromotive drug administration of lidocaine and dexamethasone followed by cystodistension in women with interstitial cystitis.  International Urogynecology Journal & Pelvic Floor Dysfunction. 1997;  8 (3) 142-145
• 53 Rossberger J, Fall M, Peeker R. Critical appraisal of dimethyl sulfoxide treatment for interstitial cystitis discomfort, side-effects and treatment outcome.  Scand J Urol Nephrol. 2005;  39 (1) 73-77
• 54 Rovner E, Propert K J, Brensinger C. et al . Treatments used in women with interstitial cystitis: the interstitial cystitis data base (ICDB) study experience. The Interstitial Cystitis Data Base Study Group.  Urology. 2000;  56 (6) 940-945
• 55 Sairanen J, Forsell T, Ruutu M. Long-term outcome of patients with interstitial cystitis treated with low dose cyclosporine A.  J Urol. 2004;  171 (6, Part 1 Of 2) 2138-2141
• 56 Sairanen J, Tammela T L, Leppilahti M. et al . Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study.  J Urol. 2005;  174 (6) 2235-2238
• 57 Sant G R, Propert K J, Hanno P M. et al . A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis.  J Urol. 2003;  170 (3) 810-815
• 58 Schulman S P, Becker L C, Kass D A. et al . L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial.  JAMA. 2006;  295 (1) 58-64
• 59 Shanberg A M, Baghdassarian R, Tansey L A. Treatment of interstitial cystitis with the neodymium-YAG laser.  Journal of Urology. 1985;  134 (5) 885-888
• 60 Shorter B, Lesser M, Moldwin R M, Kushner L. Effect of Comestibles on Symptoms of Interstitial Cystitis.  J Urol. 2007;  178 (1) 145-152
• 61 Smith C P, Radziszewski P, Borkowski A, Somogyi G T, Boone T B, Chancellor M B. Botulinum toxin a has antinociceptive effects in treating interstitial cystitis.  Urology. 2004;  64 (5) 871-875 discussion 875
• 62 Theoharides T C, Cochrane D E. Critical role of mast cells in inflammatory diseases and the effect of acute stress.  J Neuroimmunol. 2004;  146 (1 – 2) 1-12
• 63 Theoharides T C, Kempuraj D, Sant G R. Mast cell involvement in interstitial cystitis: a review of human and experimental evidence.  Urology. 2001;  57 (6 Suppl 1) 47-55
• 64 Theoharides T C, Sant G R. Hydroxyzine therapy for interstitial cystitis.  Urology. 1997;  49 (5A Suppl) 108-110
• 65 Thilagarajah R, Witherow R O, Walker M M. Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double-blind placebo-controlled trial.  BJU Int. 2001;  87 (3) 207-212
• 66 Ueda T, Tamaki M, Ogawa O, Yamauchi T, Yoshimura N. Improvement of interstitial cystitis symptoms and problems that developed during treatment with oral IPD-1151T.  J Urol. 2000;  164 (6) 1917-1920
• 67 Ophoven A van. Re: Urinary conduit formation using a retubularized bowel from continent urinary diversion or intestinal augmentations: II. Does it have a role in patients with interstitial cystitis?.  J Urol. 2005;  173 (4) 1435
• 68 Ophoven A van, Heinecke A, Hertle L. Safety and efficacy of concurrent application of oral pentosan polysulfate and subcutaneous low-dose heparin for patients with interstitial cystitis.  Urology. 2005;  66 (4) 707-711
• 69 Ophoven A, Hertle L. Long-term results of amitriptyline therapy for interstitial cystitis.  J Urol. 2005;  174 312
• 70 Ophoven A van, Hertle L. The dual serotonin and noradrenaline reuptake inhibitor duloxetine for the treatment of interstitial cystitis: results of an observational study.  J Urol. 2007;  177 (2) 552-555
• 71 Ophoven A van, Oberpenning F, Hertle L. Long-term results of trigone-preserving orthotopic substitution enterocystoplasty for interstitial cystitis.  J Urol. 2002;  167 (2 Pt 1) 603-607
• 72 Ophoven A van, Pokupic S, Heinecke A, Hertle L. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis.  J Urol. 2004;  172 (2) 533-536
• 73 Ophoven A van, Rossbach G, Oberpenning F, Hertle L. Hyperbaric oxygen for the treatment of interstitial cystitis: long-term results of a prospective pilot study.  Eur Urol. 2004;  46 (1) 108-113
• 74 Ophoven A van, Rossbach G, Pajonk F, Hertle L. Safety and efficacy of hyperbaric oxygen therapy for the treatment of interstitial cystitis: a randomized, sham controlled, double-blind trial.  J Urol. 2006;  176 (4) 1442-1446
• 75 Whitmore K E. Complementary and alternative therapies as treatment approaches for interstitial cystitis.  Rev Urol. 2002;  4 Suppl 1 S28-35
• 76 Yamada T, Murayama T, Andoh M. Adjuvant hydrodistension under epidural anesthesia for interstitial cystitis.  Int J Urol. 2003;  10 (9) 463-468
• 77 Zhang Q, Chang Q, Cox R A, Gong X, Gould L J. Hyperbaric Oxygen Attenuates Apoptosis and Decreases Inflammation in an Ischemic Wound Model.  J Invest Dermatol. 2008 Mar 13;  ISSN 1523 – 1747 (electronic), in press
• 78 Zhao J, Nordling J. Posterior tibial nerve stimulation in patients with intractable interstitial cystitis.  BJU Int. 2004;  94 (1) 101-104